Apex Healthcare Berhad

 
  DOWNLOAD ANNUAL REPORT
  FINANCIAL RESULTS
 

Board of Directors


DIRECTORS’ INFORMATION
    Datuk Noharuddin
Bin Nordin @ Harun

Senior Independent
Non-Executive Director

 
 
 
Dr Kee

Dr Kee Kirk Chin, 57, male, a Singaporean, was appointed to the Board on 15th February 2000, as the Managing Director of the Company on 3rd March 2000 and became Chairman and Chief Executive Officer on 19th May 2010. He obtained a Bachelor in Arts with Honours in 1985, a Bachelor of Medicine & Bachelor of Surgery in 1987 and a Master of Arts in 1989 from University of Cambridge, UK and a Master of Business Administration (MBA) with distinction in 1993 from University of Hull, UK. He is a registered Medical Practitioner with the Singapore Medical Council and the General Medical Council, UK. He began his career as a House Officer with National University Hospital, later joining United MediCorp Pte Ltd as Director of Business Development in 1990, becoming its Chief Executive Officer in 1996. United MediCorp had interests in several healthcare companies in six Asian countries involved in pharmaceuticals, clinical equipment, hospital support services and private hospitals. He was appointed to the Board of Singapore Corporation of Rehabilitative Enterprises on 4th April 2010 and is the Chairman of its Audit and Risk Management Committee. He was awarded the Bintang Bakti Masyarakat (Public Service Star) (BBM) by the President of the Republic of Singapore in 2015.

He is the brother of Kee Kirk Chuen. He is deemed to be a major shareholder of the Company through his deemed interest in Apex Pharmacy Holdings Sdn Bhd, a major shareholder which holds 40.43% equity in the Company. Save as disclosed, he does not have any other family relationships with any other director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2018 and has had no convictions for any offences within the past 5 years, other than traffic offences, if any and has not been imposed any public sanction or penalty by the relevant regulatory bodies during the financial year.

 
Go to Top
 
 
Robert Dobson Millner

Robert Dobson Millner, 68, male, an Australian, was appointed as a Non-Independent Non-Executive Director of the Company on 23rd February 2000. He is currently a member of the Nomination Committee. He was re-designated as a member of the Remuneration Committee on 19th August 2015. He was a farmer and grazier prior to joining the Board of Washington H Soul Pattinson & Co Limited (“WHSP”) in 1984, a company listed on the Australian Stock Exchange with principal activities in properties, coal mining, bulk handling, manufacturing, wholesaling and retailing of pharmaceutical products, and telecommunication. He was appointed Deputy Chairman of WHSP in 1997, becoming its Chairman in 1998. He is also the Chairman of Brickworks Limited, Milton Corporation Limited, New Hope Corporation Limited, and Director on the Boards of Australian Pharmaceutical Industries Limited and TPG Telecom, all of which are companies listed on the Australian Stock Exchange. He is a member of the Institute of Company Directors, New South Wales, Australia and a fellow of the Australian Institute of Directors.

He is the Chairman of WHSP, which holds 30.13% equity in the Company. He does not have any family relationship with any other director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2018 and has had no convictions for any offences within the past 5 years, other than traffic offences, if any and has not been imposed any public sanction or penalty by the relevant regulatory bodies during the financial year.

   
Go to Top
   
 
Datuk Noharuddin Bin Nordin @ Harun

Datuk Noharuddin Bin Nordin @ Harun, 63, male, a Malaysian, was appointed as an Independent Non-Executive Director of the Company on 20th May 2015. He was appointed as a member of the Audit Committee on 19th August 2015. He was appointed as Chairman of the Nomination Committee and as Senior Independent Non-Executive Director on 23rdMay 2019. He graduated with a Master of Business Administration from the University of Birmingham, UK in 1992. He has vast working experience with the Ministry of International Trade and Industry (“MITI”), Malaysia External Trade Development Corporation (“MATRADE”) and Malaysian Investment Development Authority (“MIDA”). He was the Assistant Director of MITI from 1986 to 1993. He joined MATRADE in 2000 and he was the Chief Executive Officer of MATRADE from 2006 to 2011. He was the Chief Executive Officer of MIDA from 2011 until his retirement in February 2014. He is currently a Director, and Chairman of Strategy and Business Development Committee of Kulim Technology Park Corporation Sdn Bhd. He is an Independent Director of Malaysia Venture Capital Management Berhad and Hong Leong Industries Berhad

He does not have any family relationship with any director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2018 and has had no convictions for any offences within the past 5 years, other than traffic offences, if any and has not been imposed any public sanction or penalty by the relevant regulatory bodies during the financial year.

   
  Go to Top
   
 
Mae Heng

Heng Su-Ling Mae, 48, female, a Singaporean, was appointed as an Independent Non-Executive Director of the Company on 20th November 2008. She was appointed as Chairman of the Audit Committee and ceased from office as Chairman of the Nomination Committee on 19th August 2015. She was appointed as a member of the Nomination Committee and ceased from office as a member of the Remuneration Committee on 23rd May 2019. She graduated with a Bachelor of Accountancy from Nanyang Technological University, Singapore in 1992 and is a Fellow Chartered Accountant of Singapore . She has over 16 years of experience in an audit, corporate finance and business advisory environment with Ernst and Young, Singapore. She is an Independent Director of Singapore-listed HRnetGroup Limited, Chuan Hup Holdings Limited, Ossia International Limited and Grand Venture Technology Limited.

She does not have any family relationship with any director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. She attended all of the four Board Meetings held in the financial year ended 31st December 2018 and has had no convictions for any offences within the past 5 years, other than traffic offences, if any and has not been imposed any public sanction or penalty by the relevant regulatory bodies during the financial year.

   
  Go to Top
   
 
Dr Ahmad Kamal

Datuk Phang Ah Tong, 61, male, a Malaysian, was elected as an Independent Non-Executive Director of the Company on 24th May 2018. He was appointed as Chairman of the Remuneration Committee and a member of the Audit Committee and ceased from office as a member of the Nomination Committee on 23rd May 2019. He graduated with a Bachelor of Economics (Honours) from University of Malaya in 1981. He has had a distinguished career in the civil service of Malaysia, spanning 36 years in promoting foreign and domestic investments and assisted in developing the manufacturing and services sectors in Malaysia under the Malaysian Investment Development Authority (“MIDA”) where his last held position was the Deputy Chief Executive Officer before his retirement in 2017. He has served in various capacity including being the Assistant Trade Commissioner for MIDA London and Director of MIDA New York. Upon returning to the MIDA headquarters, he was appointed the Director of Foreign Direct Investment (“FDI”), overseeing the promotion of global FDI into Malaysia. He is the Non-Executive Chairman of JF Technology Berhad and an Independent Director of Inari Amertron Berhad, Jerasia Capital Berhad and United Overseas Bank (Malaysia) Berhad.

He does not have any family relationship with any director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all three Board Meetings held in the financial year ended 31st December 2018 since the date of his appointment and has had no convictions for any offences within the past 5 years, other than traffic offences, if any and has not been imposed any public sanction or penalty by the relevant regulatory bodies during the financial year.

   
  Go to Top
   
 
Jackson Chevalier Yap-Kit-Siong

Jackson Chevalier Yap-Kit-Siong, 67, male, a Singaporean, was appointed as a Non-Independent Non-Executive Director of the Company on 15th February 2000. He was re-designated as an Independent Non-Executive Director on 25th February 2015. He was appointed as Chairman of the Remuneration Committee on 19th August 2015 and re-designated as a member of the Remuneration Committee on 23rd May 2019. He graduated with a Bachelor of Engineering with Honours from University of Auckland, New Zealand in 1974 under a Colombo Plan Scholarship. He worked in various technical and management positions in the oil and gas sector with several multinational corporations before joining United Engineers Limited (“UEL”) as Chief Operating Officer and later, Group Managing Director and Director of UEL, a company listed on the Singapore Stock Exchange, whose principal activities are in the construction and engineering of buildings, properties and environmental projects. He retired in January 2014 as CEO and from the UEL Board in April 2014.

He was a Director of Apex Pharmacy Holdings Sdn Bhd, which was holding 40.43% equity in the Company until 18th March 2014. Save as disclosed above, he does not have any other family relationships with any director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2018 and has had no convictions for any offences within the past 5 years, other than traffic offences, if any and has not been imposed any public sanction or penalty by the relevant regulatory bodies during the financial year.

   
  Go to Top
   
 
Dr Ahmad Kamal

Kee Kirk Chuen, 54, male, a Singaporean, was appointed as a Non-Independent Non-Executive Director of the Company on 18th May 2016. He obtained a Bachelor of Science (Electrical Engineering) in 1986, a Master of Engineering (M. Eng) in 1989 and a Master of Business Administration (MBA) in 1996 from Cornell University, USA. He was the Executive Director of Apex Pharmacy International Pte Ltd from 1989 to 2004. From 2005 to 2007, he was a Deputy Director at the National Council of Social Service, Singapore and a Director of Apex Holdings Pte Ltd since 2007. He joined Temasek Foundation Cares CLG Limited, a Singapore non-profit philanthropic organisation established to improve the lives of underprivileged individuals, families and communities in Singapore in 2010 and is currently holding the position of Senior Director.

He is the brother of Dr Kee Kirk Chin. He is deemed to be a major shareholder of the Company through his deemed interest in Apex Pharmacy Holdings Sdn Bhd, a major shareholder which holds 40.43% equity in the Company. Save as disclosed, he does not have any other family relationships with any other director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2018 since his date of appointment and has had no convictions for any offences within the past 5 years, other than traffic offences, if any and has not been imposed any public sanction or penalty by the relevant regulatory bodies during the financial year.

   
  Go to Top